Skip to main content
. Author manuscript; available in PMC: 2012 Feb 2.
Published in final edited form as: J Med Genet. 2009 May 7;46(7):469–471. doi: 10.1136/jmg.2009.066647

Table 3. The T1D disease duration and the anti-IA-2 association of the HLA genes.

Allele Anti- IA-2 (−) with
T1D duration ≤ 10
years vs. >10 years OR
(95% CI)		 Anti- IA-2 (+) vs.
Anti- IA-2 (−) with
T1D duration ≤10
years OR (95% CI)		 Anti- IA-2 (+) vs.
Anti- IA-2 (−) with
T1D duration >10
years OR (95% CI)
HLA-
DQB1*0201 		0.98 (0.77, 1.24) 0.67 (0.55, 0.82) 0.65 (0.53, 0.81)
HLA-DRB1*0401 0.81 (0.57, 1.15) 1.94 (1.44, 2.60) 1.57 (1.15, 2.14)
HLA-DRB1*03 0.96 (0.73, 1.27) 0.65 (0.51, 0.82) 0.62 (0.48, 0.80)
HLA-
DQA1*0501 		1.03 (0.81, 1.29) 0.70 (0.58, 0.86) 0.72 (0.58, 0.89)
HLA-A*24 1.06 (0.71, 1.58) 0.53 (0.37, 0.77) 0.57 (0.40, 0.80)